Key staff of knowledge-based companies will be exempted from military service
One of the special facilities provided to the members of knowledge-based companies is exemption of military services with the cooperation of related units. With the follow-up of the Vice-Presidency, “conscription” and “project” of service replacement are two solutions provided for these individuals.
Knowledge-based companies in the field of stem cells have exceeded the country’s capacity
While just a few number of knowledge-based companies were active in the field of stem cells in the past few years, there are now more than a hundred of technological companies in this field.
Engineering lymphatic vessels as a therapeutic to heal the heart
The cardiovascular system is a complex network of veins, arteries and capillaries. Within that network, lymphatic vessels are critical to the hearts ability to heal in the event of a heart attack.
Researchers apply fat cells to deliver drug to suppress tumor growth
Researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new drug delivery pathway that may help stop tumor growth and keep cancer from coming back in mice.
NanoSurface Biomedical expands stem cell-based technologies with acquisition of Silene Biotech
Seattle biotech company NanoSurface Biomedical, Inc., a leading provider of biomimetic cell-based assay platforms and services, announced today that it has acquired Silene Biotech, a Seattle biotechnology company focused on stem cell banking and services.
Uncovering the early origins of Huntingtons disease
With new findings, scientists may be poised to break a long impasse in research on Huntingtons disease, a fatal hereditary disorder for which there is currently no treatment.
Record-breaking gene edit disables 13,200 LINE-1 Transposons in a single cell
An international team of researchers has succeeded in making 13,200 edits to a single cell—and the cell survived. In their paper uploaded to the bioRxiv preprint server, the team describes the edits they made, how they did it and why.
Stem Cells Could Prevent Tissue Damage Caused by Radiotherapy
A new study in STEM CELLS Translational Medicine indicates mesenchymal stem cells (MSCs) are a safe and innovative option to heal normal tissue following radiotherapy. Alain Chapel, Ph.D., and Annette Larsen, DVM, Ph.D., of the Institut National de la Santé et de la Recherche Médicale (INSERM) in France led the team that conducted this research.
Defective glial cells can push neurons toward Parkinsons disease
Researchers from the University of Barcelona have shown that defective versions of human brain cells called astrocytes are linked to the buildup of a toxic protein that is the hallmark of Parkinsons disease.
Forever young: study uncovers protein that keeps skin youthful
Beauty might only be skin deep, but for those wondering how to keep that skin young, scientists may have found an answer in the form of a protein that encourages cell competition.
